Back to Search Start Over

Tucatinib Plus Trastuzumab and Capecitabine for ERBB2 (HER2)-Positive Metastatic Breast Cancer With Brain Metastases—Reply

Authors :
Nancy U. Lin
Source :
JAMA Oncology.
Publication Year :
2023
Publisher :
American Medical Association (AMA), 2023.

Subjects

Subjects :
Cancer Research
Oncology

Details

ISSN :
23742437
Database :
OpenAIRE
Journal :
JAMA Oncology
Accession number :
edsair.doi...........799d9575a9074f38ffa87a5083320f7d
Full Text :
https://doi.org/10.1001/jamaoncol.2023.1391